Evidence map›Paper›PMID 34122828›Full record

ArticleChemical science2020

Selective glucose sensing in complex media using a biomimetic receptor.

Robert A Tromans, Soumen K Samanta, Andy M Chapman, Anthony P Davis

Abstract read
In one paragraph

Article in Chemical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. A Synthetic Lectin for Glucuronate.ACS central science · 2025
    Article
  3. Review
  4. Acyclic cucurbit[Beilstein journal of organic chemistry · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review: Glucose-sensitive insulin.Molecular metabolism · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Robert A TromansSchool of Chemistry, University of Bristol Cantock's Close Bristol BS8 1TS UK Anthony.Davis@bristol.ac.uk.
Soumen K SamantaSchool of Chemistry, University of Bristol Cantock's Close Bristol BS8 1TS UK Anthony.Davis@bristol.ac.uk.
Andy M ChapmanCarbometrics Ltd., Unit DX St Philips Central, Albert Road Bristol BS2 0XJ UK.
Anthony P DavisSchool of Chemistry, University of Bristol Cantock's Close Bristol BS8 1TS UK Anthony.Davis@bristol.ac.uk.ORCID https://orcid.org/0000-0001-5213-624X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glucose is a key biomedical analyte, especially relevant to the management of diabetes. Current methods for glucose determination rely on the enzyme glucose oxidase, requiring specialist instrumentation and suffering from redox-active interferents. In a new approach, a powerful and highly selective achiral glucose receptor is mixed with a sample, l-glucose is added, and the induced CD spectrum is measured. The CD signal results from competition between the enantiomers, and is used to determine the d-glucose content. The involvement of l-glucose doubles the signal range from the CD spectrometer and allows sensitivity to be adjusted over a wide dynamic range. It also negates medium effects, which must be equal for both enantiomers. The method has been demonstrated with human serum, pre-filtered to remove proteins, giving results which closely match the standard biochemical procedures, as well as a cell culture medium and a beer sample containing high (70 mM) and low (0.4 mM) glucose concentrations respectively.

Identifiers

PMID34122828
PMCPMC8157503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.